Target intelligence / Profile preview

Acetylserotonin O-methyltransferase-like protein (ASMTL)

Target
ASMTL
Molecular classification
Enzyme, Methyltransferase, Nucleoside triphosphate pyrophosphatase
01

Overview

Acetylserotonin O-methyltransferase-like protein (ASMTL) is a bifunctional enzyme encoded by the ASMTL gene, located in the pseudoautosomal region of the X and Y chromosomes in humans. It possesses two distinct functional domains: an N-terminal domain homologous to bacterial Maf proteins and a C-terminal domain similar to N-acetylserotonin O-methyltransferase (ASMT). ASMTL hydrolyzes dTTP and UTP (and to a lesser extent other nucleotides), suggesting a role in nucleotide metabolism and potentially in preventing the incorporation of modified nucleotides into nucleic acids. Although its C-terminal domain implies possible methyltransferase activity, direct enzymatic activity for N-acetylserotonin methylation by ASMTL is not well established in contrast to its paralog ASMT. ASMTL is expressed in various tissues, where it may regulate cell division and nucleotide pool balance. Its precise physiological function and disease associations are still under investigation[2][3][5].

Other names
ASMTLAcetylserotonin O-methyltransferase likeAcetylserotonin O-methyltransferase-like proteinN-acetylserotonin O-methyltransferase-like proteinASMTLXASMTLYASTMLProbable bifunctional dTTP/UTP pyrophosphatase/methyltransferase proteindTTP/UTP pyrophosphataseNucleotide PPaseNucleoside triphosphate pyrophosphataseNucleotide pyrophosphatase
02

Biological functions

Methylation of N-acetylserotonin (putative/weak evidence)Hydrolysis of dTTP and UTP (pyrophosphatase activity)Regulation of nucleotide poolsPossible involvement in cell division arrestPossible protection against incorporation of modified nucleotides into nucleic acids[3]
03

Disease associations

Cancer (including hematologic cancer and melanotic neurilemmoma)[3]Potential link to neuropsychiatric disorders via paralog ASMT, but disease involvement of ASMTL itself is less characterized

Beyond the preview

Go deeper on Acetylserotonin O-methyltransferase-like protein (ASMTL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acetylserotonin O-methyltransferase-like protein (ASMTL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call